FAQ/Help |
Calendar |
Search |
Today's Posts |
|
06-21-2019, 06:02 AM | #1 | ||
|
|||
Member
|
It's only a couple of days old, but there are quite a few articles on this already. This article is the most sober one I could find.
'Brain changes' could provide early warning sign for Parkinson's disease - NHS |
||
Reply With Quote |
06-21-2019, 09:03 PM | #2 | |||
|
||||
Grand Magnate
|
Thanks jeffreyn; that looks very encouraging to me.
__________________
Knowledge is power. |
|||
Reply With Quote |
06-30-2019, 01:10 AM | #3 | ||
|
|||
Member
|
The AlzForum website has just published a fairly solid article covering this research (i.e. something that sits between the NHS article and the research paper itself).
Does Serotonin Pathology Foreshadow Parkinson’s Disease? | ALZFORUM |
||
Reply With Quote |
06-30-2019, 09:26 AM | #4 | ||
|
|||
Senior Member
|
So, dopamine deficiency is not the whole story with PD: serotonin plays a part too.
"The researchers found that in pre-symptomatic people with a hereditary risk of Parkinson's there was a loss of serotonin in several areas of the brain that are known to be affected in Parkinson's. Therefore this could be a change that happens in the early stages of Parkinson's." The thing I can't understand is why this research isn't translated into a simple serotonin based therapy. The same goes for the other neurotransmitters. John
__________________
Born 1955. Diagnosed PD 2005. Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg |
||
Reply With Quote |
07-01-2019, 12:13 AM | #5 | ||
|
|||
Member
|
Hi johnt,
When you say "a simple serotonin based therapy", do you mean something like giving PwPs the serotonin precursor 5-HTP (plus the equivalent of carbidopa?) to make up for the reduced level of serotonin? There may be research going on in this area, but I've not come across it (except for the Hinz protocol). |
||
Reply With Quote |
07-01-2019, 03:24 AM | #6 | |||
|
||||
Grand Magnate
|
The aldehyde form of serotonin promotes formation of alpha-synuclein oligomers and serotonin blocks formation of amyloid from alpha-synuclein.
Whether these are clinically relevant remains to be seen. The serotonin aldehyde, 5-HIAL, oligomerizes alpha-synuclein. - PubMed - NCBI The neurotransmitter serotonin interrupts α-synuclein amyloid maturation. - PubMed - NCBI
__________________
Knowledge is power. |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Normast Add-on Therapy Reduces Motor, Non-motor Symptoms in Parkinson's Patients, Stu | Parkinson's News | |||
The impact of high intensity physical training on motor and non-motor symptoms in pat | Parkinson's Disease |